B

BIKEN at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

BIKEN takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 226. Its sessions cover early research on vaccines against Enterovirus D68 and late-stage clinical work on influenza. The most concrete is a Phase III study of an intranasal, quadrivalent, inactivated whole-virus influenza vaccine in healthy Japanese people aged 13 to 64.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
B
BIKEN
Large pharmaSilver sponsor
Japanese vaccine maker linked to Osaka University, producing influenza and other vaccines.
Booth
Exhibiting at Booth 226
Talk
Tue Oct 20
14:30
Research and development of vaccines against Enterovirus D68
Pre-Clinical Development
Talk
Wed Oct 21
11:30

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from BIKEN

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction